Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 0.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,772,239 shares of the company’s stock after selling 20,738 shares during the quarter. Vanguard Group Inc. owned 0.13% of Cardinal Health worth $3,639,433,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. State Street Corp boosted its position in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after buying an additional 627,253 shares during the period. Geode Capital Management LLC raised its stake in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after acquiring an additional 42,082 shares in the last quarter. Amundi boosted its holdings in Cardinal Health by 5.5% in the fourth quarter. Amundi now owns 2,116,291 shares of the company’s stock valued at $259,309,000 after purchasing an additional 110,605 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Cardinal Health by 3.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company’s stock worth $179,653,000 after purchasing an additional 44,386 shares in the last quarter. Finally, Two Sigma Advisers LP increased its holdings in Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after purchasing an additional 346,362 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $133.25 on Tuesday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $133.67. The stock has a market capitalization of $32.19 billion, a P/E ratio of 24.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The business’s 50-day simple moving average is $127.60 and its 200-day simple moving average is $120.24.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is currently 37.69%.

Analyst Ratings Changes

CAH has been the subject of several recent research reports. Wells Fargo & Company lifted their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.